Cannara Biotech (OTCMKTS:CNBTF) Shares Down 1% – Time to Sell?

Cannara Biotech (OTCMKTS:CNBTF – Get Free Report)’s share price fell 1% on Tuesday . The stock traded as low as $1.23 and last traded at $1.24. 10,275 shares traded hands during mid-day trading, a decline of 69% from the average session volume of 33,127 shares. The stock had previously closed at $1.2520.

Cannara Biotech Price Performance

The firm’s 50 day simple moving average is $1.31 and its two-hundred day simple moving average is $1.29.

Get Cannara Biotech alerts:

Cannara Biotech Holdings Inc (OTCMKTS:CNBTF) is a biotechnology and natural health company focused on the development, production and distribution of plant-derived formulations, including cannabinoid-based products. Headquartered in Canada, the company integrates research and development with large-scale extraction and formulation processes to serve the pharmaceutical, cosmetic and wellness industries.

The company’s offerings comprise high-purity botanical extracts, nutraceutical ingredients and cosmetic actives developed using proprietary extraction and purification techniques.

See Also

• Five stocks we like better than Cannara Biotech
• Meta Platforms 10% Layoff Raises a Bigger Question About AI Spending
• As Small-Cap Outperformance Continues, These 2 ETFs Provide Exposure
• Silicon Shake-Up: The AI Trade Is Moving Beyond NVIDIA
• The Silver Lining of Last Week’s Hims & Hers Earnings Miss

Receive News & Ratings for Cannara Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cannara Biotech and related companies with MarketBeat.com's FREE daily email newsletter.